SCHEMBL15936003

SCHEMBL15936003

CN1CNCC2NCNC=C21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1176977 0.63
SCHEMBL27035778 0.59 PLG (0.38)
SCHEMBL4698269 0.54
SCHEMBL24511191 0.52
SCHEMBL14064625 0.49
SCHEMBL329297 0.49
SCHEMBL20054226 0.48 CTSL (0.30)
SCHEMBL21229546 0.48 PRCP (0.44)
SCHEMBL26775198 0.48
SCHEMBL29563835 0.47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105892155-A Method For Producing Liquid Crystal Alignment Film, Method For Producing Liquid Crystal Display Device And Liquid Crystal Display Device 富士胶片株式会社 2016-08-24 CN disclosed
US-9040697-B2 Process for the production of moxonidine AREVIPHARMA GMBH (DE) 2015-05-26 US disclosed
US-20140228383-A1 PROCESS FOR THE PRODUCTION OF MOXONIDINE AREVIPHARMA GMBH (DE) 2014-08-14 US disclosed
EP-2765131-A1 Process for the production of Moxonidine Arevipharma GmbH (DE) 2014-08-13 EP disclosed